Puretech Health Share Discussion Threads

[lendmeafiver] 31/1/2023 10:10

Anyone know how much of the buyback they have used to date?

[lendmeafiver] 30/1/2023 11:27

Random isn’t it

[edwardt] 25/1/2023 08:59

It appears to be back

[lendmeafiver] 17/1/2023 15:38

Are they still doing a buyback?

[edwardt] 06/1/2023 08:29

following the great news from akili, i thought i would add the size of the tam.
the global attention deficit hyperactivity disorder market size was valued at USD 13.21 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 4.2% from 2023 to 2030.

15% of that market will do us nicely!

[rogers49] 12/12/2022 16:05

Agree, PRTC should be a lot higher.

[edwardt] 12/12/2022 15:47

nice rns. the venclexta drug referenced as a comparable has annual sales of $505m with abbvie. lets eat into that pie.

[rambutan2] 09/12/2022 23:02

Agree, I've always had high hopes for their tech.

https://uk.advfn.com/stock-market/london/puretech-health-PRTC/share-news/PureTech-Health-PLC-Sonde-Gets-19M-for-Voice-Bas/89746131

[edwardt] 09/12/2022 17:56

Decent raise for sonde - glad we followed our money there

[edwardt] 07/12/2022 18:48

Vor roars!

[rambutan2] 02/12/2022 20:27

Just spotted this, which I guess has helped sentiment:

30/11/22 Today, the U.S. Food and Drug Administration approved Rebyota, the first fecal microbiota product approved by the agency. Rebyota is approved for the prevention of recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older.

hTTps://www.fda.gov/news-events/press-announcements/fda-approves-first-fecal-microbiota-product

[af004] 28/11/2022 09:53

Not sure but looks like we are heading for £3

[edwardt] 21/11/2022 13:58

anyone know why this has perked up today?

[rambutan2] 11/10/2022 13:29

Has raised doubts about Daphne and co's competence and intentions and the quality of the portfolio I would have thought. Had they not read up on UK takeover framework, or thought about how the mkt might view the deal etc etc. All a bit Trussian. Now they are going to have to earn back the mkt's confidence. imho

[liam1om] 11/10/2022 07:15

So PRTC sees a large drop on offer talks. You would assume once offer talks were off the price rebounds?

[babbler] 11/10/2022 07:14

yes and predicted.

[edwardt] 11/10/2022 07:05

i think that is probably for the best!

[rambutan2] 10/10/2022 13:30

So, all is unclear as to what exactly is going on!

hTTps://www.fiercebiotech.com/biotech/puretech-confirms-nektar-merger-rumors-potential-lifeline-former-bms-partner

[rambutan2] 10/10/2022 13:26

Hmmm:

"Mizuho analysts suggest a more prosaic reason for tying the companies up: Puretech’s president is Bharat Chowiria, and he had once served as chairman and chief business officer of Nektar. Still, back then Nektar was focusing on inhaled insulin, and had yet to turn to oncology, the strategy that yielded bempegaldesleukin."

hTtps://www.evaluate.com/vantage/articles/news/deals/nektar-and-puretech-make-strange-bedfellows

[rambutan2] 10/10/2022 13:18

Trying to get my head round what going on:

"The clinical setback knocked $1 billion off of Nektar’s market capitalization, and at Thursday’s $3.38-a-share close the company valuation was $633 million, slightly above its $619 million in cash holdings as of June 30."

htTps://www.biopharmadive.com/news/nektar-puretech-acquisition-talks/633594/

[edwardt] 07/10/2022 15:23

i note invesco are biggest shareholders of both. but yes - reaction probably a bit harsh as they have not agreed to anything.

[babbler] 07/10/2022 15:19

tbf it's a proposal to them. They had to let shareholders know. They likely will reject it. Then can move back up.